HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akihiro Homma Selected Research

Cetuximab (Erbitux)

11/2022Real-world clinical outcomes in Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated with radiotherapy plus cetuximab: a prospective observational study (JROSG12-2).
6/2021Effectiveness of nivolumab affected by prior cetuximab use and neck dissection in Japanese patients with recurrent or metastatic head and neck cancer: results from a retrospective observational study in a real-world setting.
2/2021Real-world clinical outcomes and prognostic factors in Japanese patients with recurrent or metastatic squamous cell carcinoma of head and neck treated with chemotherapy plus cetuximab: a prospective observation study (JROSG12-2).
1/2021Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck.
1/2020A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck.
5/2019Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
8/2015Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in Japan.
5/2013Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: results of a phase II trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akihiro Homma Research Topics

Disease

48Neoplasms (Cancer)
04/2024 - 09/2004
40Squamous Cell Carcinoma of Head and Neck
03/2024 - 09/2004
27Head and Neck Neoplasms (Head and Neck Cancer)
12/2023 - 01/2005
14Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2024 - 03/2005
10Carcinoma (Carcinomatosis)
04/2022 - 03/2005
9Neoplasm Metastasis (Metastasis)
09/2023 - 10/2012
8Lymphatic Metastasis
05/2024 - 08/2004
7Otitis Media
04/2024 - 01/2012
6Vasculitis (Vasculitides)
04/2024 - 01/2012
6Maxillary Sinus Neoplasms
11/2023 - 10/2014
6Hypopharyngeal Neoplasms
02/2023 - 11/2010
5Laryngeal Neoplasms (Laryngeal Cancer)
05/2024 - 12/2008
5Stomatitis
08/2019 - 01/2015
5Tongue Neoplasms (Tongue Neoplasm)
04/2019 - 07/2011
4Mucositis
11/2023 - 01/2015
4Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2022 - 01/2012
4Rhinosinusitis
10/2021 - 10/2018
3Neutropenia
11/2023 - 11/2004
3Adenoid Cystic Carcinoma (Cylindroma)
04/2022 - 03/2005
3Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma)
02/2022 - 03/2006
3Dermatitis
11/2021 - 08/2015
3Oropharyngeal Neoplasms
07/2017 - 01/2013
2Hearing Loss (Hearing Impairment)
11/2023 - 01/2016
2Melanoma (Melanoma, Malignant)
11/2023 - 09/2023
2Thyroid Neoplasms (Thyroid Cancer)
07/2023 - 01/2018
2Inflammation (Inflammations)
01/2022 - 07/2017
2Nasal Polyps (Nasal Polyp)
10/2021 - 10/2018
2Infections
06/2021 - 07/2017
2COVID-19
06/2021 - 01/2021
2Asthma (Bronchial Asthma)
04/2021 - 01/2019
2Deglutition Disorders (Dysphagia)
03/2021 - 01/2016
2Vertigo (Positional Vertigo)
03/2021 - 01/2016
2Disease Progression
01/2021 - 10/2020
2Paralysis (Palsy)
08/2019 - 04/2019
2Body Weight (Weight, Body)
04/2019 - 01/2015
2Sensorineural Hearing Loss
10/2018 - 01/2016
2Cysts
12/2014 - 03/2006
2Sinusitis
01/2012 - 03/2006
2Wounds and Injuries (Trauma)
01/2010 - 12/2008
1Nasopharyngeal Carcinoma
03/2024
1Stroke (Strokes)
11/2023
1Hypoparathyroidism
11/2023
1Sarcoma (Soft Tissue Sarcoma)
08/2023
1Second Primary Neoplasms (Neoplasms, Second)
06/2023

Drug/Important Bio-Agent (IBA)

33Cisplatin (Platino)FDA LinkGeneric
03/2024 - 09/2004
8Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
04/2024 - 01/2012
8Cetuximab (Erbitux)FDA Link
11/2022 - 05/2013
8Biomarkers (Surrogate Marker)IBA
09/2022 - 02/2017
6PlatinumIBA
01/2022 - 10/2012
6Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2005
5Carboplatin (JM8)FDA LinkGeneric
01/2020 - 09/2004
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2018
4Peroxidase (Myeloperoxidase)IBA
01/2022 - 01/2012
4NivolumabIBA
01/2022 - 03/2021
3Fluorouracil (Carac)FDA LinkGeneric
09/2023 - 05/2013
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
07/2023 - 01/2018
3SteroidsIBA
11/2021 - 01/2016
3Cyclin D1IBA
02/2017 - 10/2007
3Docetaxel (Taxotere)FDA Link
06/2015 - 10/2007
2Protons (Proton)IBA
08/2023 - 07/2022
2lenvatinibIBA
07/2023 - 01/2018
2Indicators and Reagents (Reagents)IBA
06/2023 - 09/2013
2ZincIBA
10/2021 - 04/2021
2Serum AlbuminIBA
07/2021 - 01/2015
2CytokinesIBA
01/2021 - 01/2005
2Immune Checkpoint InhibitorsIBA
10/2020 - 09/2020
2Immunoglobulins (Immunoglobulin)IBA
01/2019 - 04/2016
2EnzymesIBA
10/2018 - 01/2016
2IodineIBA
01/2018 - 01/2016
2RhodaminesIBA
01/2018 - 01/2016
2CyclinsIBA
09/2013 - 10/2007
1Deoxyribonucleases (DNase)FDA Link
04/2024
1Deoxyribonuclease I (Nickase)IBA
04/2024
1CreatinineIBA
11/2023
1CateninsIBA
11/2023
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2023
1Imiquimod (Aldara)FDA LinkGeneric
09/2023
1CholesterolIBA
01/2023

Therapy/Procedure

50Radiotherapy
03/2024 - 09/2004
40Chemoradiotherapy
05/2024 - 09/2004
19Neck Dissection (Radical Neck Dissection)
05/2024 - 08/2004
19Therapeutics
11/2023 - 04/2015
18Drug Therapy (Chemotherapy)
12/2023 - 11/2004
11Intra-Arterial Infusions
11/2023 - 12/2006
4Tracheostomy
11/2023 - 07/2017
4Operative Surgical Procedures
09/2022 - 08/2014
4Aftercare (After-Treatment)
07/2017 - 04/2009
3Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
03/2024 - 03/2005
3Induction Chemotherapy
02/2021 - 06/2015
3Laryngectomy
01/2010 - 12/2008
2Thyroidectomy
11/2023 - 08/2004
2Adjuvant Radiotherapy
09/2023 - 08/2017
2Combined Modality Therapy
02/2022 - 10/2012
2Glossectomy
04/2019 - 12/2018
2Brachytherapy
08/2008 - 12/2006
1Catheters
04/2024
1Punctures
04/2024
1Lymph Node Excision (Lymph Node Dissection)
11/2023
1Molecular Targeted Therapy
11/2023
1Heavy Ion Radiotherapy
08/2023